Investment analysts at StockNews.com initiated coverage on shares of Arch Biopartners (NYSE:ARCH – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the stock.
Arch Biopartners Price Performance
Shares of Arch Biopartners stock opened at $134.83 on Thursday. Arch Biopartners has a 1 year low of $116.44 and a 1 year high of $180.65.
Institutional Investors Weigh In On Arch Biopartners
An institutional investor recently bought a new position in Arch Biopartners stock. Total Clarity Wealth Management Inc. purchased a new position in Arch Biopartners Inc. (NYSE:ARCH – Free Report) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 329 shares of the company’s stock, valued at approximately $47,000.
Featured Articles
- Five stocks we like better than Arch Biopartners
- Stock Sentiment Analysis: How it Works
- Short Sellers Gave Up on These 3 Names Recently
- Asset Allocation Strategies in Volatile Markets
- 3 Boring Stocks Outperforming the Market This Year
- Buy P&G Now, Before It Sets A New All-Time High
- If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
Receive News & Ratings for Arch Biopartners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Biopartners and related companies with MarketBeat.com's FREE daily email newsletter.
